Upload others
View 3
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Biocon brief
NIMOTUZUMAB INJECTION NIMOTUZUMAB INJECTION PI.pdf · or call toll free No: 1800 102 9465 e mail us at [email protected] Please refer to carton/label. Biocon House, Semicon Park,
Biocon Vikash presentation
Ppt on Biocon
Biocon presentation
biocon lmtd
Aula Bevacizumab - Zulim
MFOLFOX-bevacizumab or XELOX- bevacizumab then bevacizumab alone or with erlotinib in 1st line treatment of patients with metastatic colorectal cancer
Biocon Group Ppt
Biocon (BIOCON) Rs 567 - ICICI Directcontent.icicidirect.com/mailimages/Biocon -final.pdf · Biocon India incorporated as 70:30 JV between Indian promoters & Irish company Biocon
Biocon Q4_FY12_Media Presentation
Biocon Q4FY12_Investor Presentation_April_2012
bevacizumab - folfox -6
Biocon Case Study
BIOCON- HRD
Biocon Limited Investor Presentation - Biocon - India's ... PPT_Nov 2017.pdf · Biocon Limited Investor Presentation November 2017 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS
Biocon Biologics Limited
Brand Biocon
Biocon Case
Biocon Investor Presentation_Q3_FY12
Biocon Cre To
Biocon III system Biocon III synoptic data Protection not ... · Biocon III system Biocon III synoptic data System capacity: 43.800 liters/Day Organic load capacity: 22,56 kg BOD5/Day
2010-2012 - Biocon
Biocon Ppt
Biocon Investor Presentation_Oct_2011_H1
Biocon final
biocon stm
Avastin, INN-bevacizumab
~$Biocon · About Biocon Biologics: Biocon Biologics is a subsidiary of Biocon Ltd, an innovation led global biopharmaceuticals company. Biocon Biologics is engaged in developing
Biocon FY2014 Results
